Glucotrack (GCTK) Income from Continuing Operations (2010 - 2025)
Glucotrack's (GCTK) quarterly Income from Continuing Operations came in at 3419000.0 in Q4 2025, up 11.86% YoY from 3056533.99 in Q4 2024, and up 21.37% on a QoQ basis from 4348000.0 in Q3 2025.
Glucotrack (GCTK) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 15 years of Income from Continuing Operations data on file, last reported at 3419000.0 in Q4 2025.
- Quarterly Income from Continuing Operations rose 11.86% year-over-year to 3419000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 16142000.0 (down 9.47% YoY) and the FY2025 annual result came in at 16142000.0, down 10.47% from the prior year.
- Income from Continuing Operations advanced to 3419000.0 in Q4 2025, from 4348000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 838000.0 in Q3 2021 to a low of 4873000.0 in Q2 2025.
- A 5-year average of 2335550.0 and a median of 1886000.0 in 2021 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations advanced 20.08% — and 2024, when it plunged 287.7%.
- Tracing GCTK's Income from Continuing Operations over 5 years: stood at 1548000.0 in 2021, then advanced by 16.86% to 1287000.0 in 2022, then plunged by 88.58% to 2427000.0 in 2023, then slumped by 59.83% to 3879000.0 in 2024, then gained by 11.86% to 3419000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 3419000.0 (Q4 2025), 4348000.0 (Q3 2025), and 4873000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | -3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.42 Mn |
| Sep 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.50 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -930,000.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -1.55 Mn |
| Sep 30, 2021 | -838,000.00 |
| Jun 30, 2021 | -981,000.00 |
| Mar 31, 2021 | -910,000.00 |